These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17410118)

  • 1. Pharmacokinetics of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (CTHC) after intravenous administration of CTHC in healthy human subjects.
    Glaz-Sandberg A; Dietz L; Nguyen H; Oberwittler H; Aderjan R; Mikus G
    Clin Pharmacol Ther; 2007 Jul; 82(1):63-9. PubMed ID: 17410118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Large White Pig as an animal model for the study of cannabinoids metabolism: application to the study of THC distribution in tissues.
    Brunet B; Doucet C; Venisse N; Hauet T; Hébrard W; Papet Y; Mauco G; Mura P
    Forensic Sci Int; 2006 Sep; 161(2-3):169-74. PubMed ID: 16859848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The urinary disposition of intravenously administered 11-nor-9-carboxy-delta-9-tetrahydrocannabinol in humans.
    Dietz L; Glaz-Sandberg A; Nguyen H; Skopp G; Mikus G; Aderjan R
    Ther Drug Monit; 2007 Jun; 29(3):368-72. PubMed ID: 17529896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.
    Brenneisen R; Egli A; Elsohly MA; Henn V; Spiess Y
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):446-52. PubMed ID: 8897084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intrapulmonary tetrahydrocannabinol administration in humans.
    Zuurman L; Roy C; Schoemaker RC; Hazekamp A; den Hartigh J; Bender JC; Verpoorte R; Pinquier JL; Cohen AF; van Gerven JM
    J Psychopharmacol; 2008 Sep; 22(7):707-16. PubMed ID: 18515447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration-effect relationship of delta-9-tetrahydrocannabiol and prediction of psychotropic effects after smoking marijuana.
    Harder S; Rietbrock S
    Int J Clin Pharmacol Ther; 1997 Apr; 35(4):155-9. PubMed ID: 9112136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users.
    Ohlsson A; Lindgren JE; Wahlén A; Agurell S; Hollister LE; Gillespie HK
    Biomed Mass Spectrom; 1982 Jan; 9(1):6-10. PubMed ID: 6277407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interpretation of blood analysis data found after passive exposure to cannabis].
    Toennes SW; Röhrich J; Wunder C
    Arch Kriminol; 2010; 225(3-4):90-8. PubMed ID: 20506708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling of the concentration--effect relationship of THC on central nervous system parameters and heart rate -- insight into its mechanisms of action and a tool for clinical research and development of cannabinoids.
    Strougo A; Zuurman L; Roy C; Pinquier JL; van Gerven JM; Cohen AF; Schoemaker RC
    J Psychopharmacol; 2008 Sep; 22(7):717-26. PubMed ID: 18583433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis.
    Joerger M; Wilkins J; Fagagnini S; Baldinger R; Brenneisen R; Schneider U; Goldman B; Weber M
    Drug Metab Lett; 2012 Jun; 6(2):102-8. PubMed ID: 22594565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of Delta tetrahydrocannabinol in CF1 mice deficient in mdr1a P-glycoprotein.
    Bonhomme-Faivre L; Benyamina A; Reynaud M; Farinotti R; Abbara C
    Addict Biol; 2008 Sep; 13(3-4):295-300. PubMed ID: 18331373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Delta-9-tetrahydrocannabinol pharmacokinetics].
    Goullé JP; Saussereau E; Lacroix C
    Ann Pharm Fr; 2008 Aug; 66(4):232-44. PubMed ID: 18847571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance and disposition of tetrahydrocannabinol in man.
    Hunt CA; Jones RT
    J Pharmacol Exp Ther; 1980 Oct; 215(1):35-44. PubMed ID: 6256518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium carbonate as a potential pharmacological vehicle: intravenous kinetics of single-dose administration in healthy subjects.
    Waring WS; Webb DJ; Maxwell SR
    Eur J Clin Pharmacol; 2002 Sep; 58(6):431-4. PubMed ID: 12242603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men.
    Puttonen J; Laine T; Ramela M; Häkkinen S; Zhang W; Pradhan R; Pentikäinen P; Koskinen M
    Eur J Pharm Sci; 2007 Dec; 32(4-5):271-7. PubMed ID: 17888637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis.
    Khiabani HZ; Mørland J; Bramness JG
    Eur J Intern Med; 2008 Dec; 19(8):608-12. PubMed ID: 19046727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous analysis of THC and its metabolites in blood using liquid chromatography-tandem mass spectrometry.
    Del Mar Ramirez Fernandez M; De Boeck G; Wood M; Lopez-Rivadulla M; Samyn N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(2):465-70. PubMed ID: 18922747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydrocannabinols in clinical and forensic toxicology.
    Kochanowski M; Kała M
    Przegl Lek; 2005; 62(6):576-80. PubMed ID: 16225128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
    Mao ZL; Stalker D; Keirns J
    Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.